Health Check-Up Industry
The global health check-up market was valued at USD 48.71 billion in 2022 and is anticipated to experience a robust growth rate, projected at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030. This growth can be largely attributed to several factors, including the rising prevalence of chronic diseases, increased investments from government agencies to implement population medical screening initiatives, and a growing adoption of telemedicine and home-based healthcare services. A notable example is the initiative launched by the Indian Health Ministry in May 2023, aimed at providing medical screening for individuals suffering from hypertension and diabetes. This program is designed to deliver standardized care to approximately 75 million individuals grappling with non-communicable diseases by the year 2025.
The COVID-19 pandemic has also played a significant role in shaping the health check-up market, particularly through the introduction of telemedicine in general healthcare practices. This shift has stimulated the home-based testing market and reinforced the digital connectivity framework within the healthcare ecosystem. Furthermore, the increasing incidence of life-threatening diseases remains a critical driver for the industry. Non-communicable diseases, such as diabetes, hypertension, cancer, and cardiovascular diseases, have been on the rise, often remaining asymptomatic in their early stages. For instance, an article from the AMGA indicates that more than 30% of the U.S. population is affected by prehypertension, which significantly raises the likelihood of developing high blood pressure. Regular health check-ups empower individuals to effectively manage these conditions, especially considering that only 1 in 4 U.S. adults currently have their hypertension under control.
In response to the growing health crisis, various government bodies are implementing initiatives aimed at screening target populations for different medical conditions. For example, the U.S. Preventive Services Task Force (USPSTF) recommends annual blood pressure screening for all adults aged 18 and older to better manage risks associated with hypertension. Likewise, Middle Eastern countries have started medical screening programs to enhance public awareness regarding the rising prevalence of hypertension. A pertinent initiative occurred in May 2023 when the Ministry of Health and Prevention (MoHAP) in the UAE launched a national campaign focused on the early detection of hypertension. The UAE aims to achieve a 30% reduction in high blood pressure prevalence by 2030. Consequently, the increasing recommendations and proactive measures from government agencies are expected to be key drivers of growth in the global health check-up market.
Gather more insights about the market drivers, restrains and growth of the Health Check-Up Market
Type Insights
- The general health check-up segment held the largest market share of 84% in 2022. This segment provides a comprehensive overview of an individual’s health, enabling the identification of risk factors and the management of health conditions at their early stages.
- Healthcare professionals widely recommend general health check-ups because they play a crucial role in reducing future disease burdens. These assessments help individuals understand their overall health status and take proactive measures to mitigate potential health risks.
- As more individuals focus on proactively managing their well-being, this trend is expected to drive market growth during the forecast period. Awareness about the importance of regular check-ups is increasing, leading to more people seeking these services.
- Additionally, insurance companies are enhancing market growth by offering preventive medical services with no-cost sharing benefits. This means that insured individuals can access essential health screenings without financial barriers, encouraging greater participation in health check-up programs.
- For example, a May 2023 article by the Kaiser Family Foundation (KFF) estimated that 6 million U.S. citizens were covered by private insurance plans that include a preventive no-cost sharing policy. This policy incentivizes individuals to take charge of their health by removing cost as a barrier to accessing preventive care.
- The specialized health check-up segment is anticipated to exhibit the fastest growth rate during the forecast period. Specialized health check-ups concentrate on specific health areas, including cardiovascular health, cancer screenings, metabolic disorders, and genetic predispositions.
- These targeted screenings and tests provide individuals with a comprehensive assessment, allowing for early detection of condition-specific risks, which is vital for effective management and treatment.
- For instance, according to Cancer Research UK, an estimated 1 million people worldwide develop cancer each year, with deaths exceeding 10 million annually.
- However, the World Health Organization (WHO) reports that 30% to 50% of all cancer cases and deaths are preventable through diligent targeted screening. This highlights the critical importance of specialized health check-ups in early detection and prevention strategies.
Order a free sample PDF of the Health Check-Up Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
